Results 121 to 130 of about 1,744 (184)

PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY [PDF]

open access: yesValue in Health, 2019
M. Rotundo   +3 more
openaire   +1 more source

Development of a new patient reported outcome (PRO) measure for acute bacterial skin and skin structure infections (ABSSSI) [PDF]

open access: yesValue in Health, 2013
Powers, J.H.   +8 more
openaire   +2 more sources

Characteristics of Patients Hospitalized for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) From 2009 to 2013 [PDF]

open access: yesOpen Forum Infectious Diseases, 2016
Emily Mcginnis   +4 more
openaire   +1 more source

Acute bacterial skin and skin structure infections (ABSSSI) signs/ symptoms and pros: A comprehensive literature review [PDF]

open access: yesValue in Health, 2013
Cimms, T.A.   +7 more
openaire   +1 more source

Leukocytoclastic Vasculitis Induced by Dalbavancin: A Case Report. [PDF]

open access: yesAm J Case Rep
Scaglione V   +7 more
europepmc   +1 more source

Expert Opin Drug Metab Toxicol [PDF]

open access: yes
Introduction:Tedizolid is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Although tedizolid shares many similar properties with linezolid, another oxazolidinone used to treat ABSSSI, the two antibiotics have ...

core  

679Ceftaroline Fosamil (CPT-F) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients [PDF]

open access: yesOpen Forum Infectious Diseases, 2014
Kaye, Keith   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy